US Patent Issued to Shenzhen Turier Biotech on Sept. 15 for "Peptide compound targeting elastin-derived peptides and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,454, issued on Sept. 15, was assigned to Shenzhen Turier Biotech Co. Ltd. (China).

"Peptide compound targeting elastin-derived peptides and use thereof" was invented by Xianxing Jiang (Shenzhen, China), Rui Wang (Shenzhen, China) and Nazi Song (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptide compound targeting elastin-derived peptides and use thereof. The peptide comprises a parent peptide represented by the following amino acid sequence: R1-Val-Xa2-Gly-Ser-Pro-Ser-Ala-Gln-Xa9-Xa10-Ala-Ser-Pro-Xa14, and is characterized by better biological activity, higher safety and stability, high synthesis...